An Introduction to treat mesothelioma
The traditional therapies are of little benefit for Mesothelioma Treatment. The survival rate after diagnosis is in the order of 6 to 12 months. The spread of malignant cells in the underlying tissue, and other organs pleural fibrosis in the cave, the cave pleural fibrosis promote local metastases exfoliée cells, the non-active period between asbestos exposure and the development of the disease are among the main reasons for the malignancy is not the treatments.
Surgery mesothelioma can to alleviate the pain and discomfort by the tumor or to heal the patient. Solutions that surgery is, in those cases in which the tumor is already beyond the mésothélium reproduced, and is difficult to remove completely or, in cases where the patient is too sick for a more complete. Curative surgery is offered if the patient is healthy and in the tumor is in the thoughts and can be completely removed.
The mesothelioma is very resistant to radiation therapy and chemotherapy. These treatments are essentially alleviating the symptoms of metastatic tumor cells. The Food and Drug Administration in February 2004, the use of pemetrexed, the brand name Alimta for the treatment of malignant pleural mesothelioma.
Mesothelioma reacted positively to the aid of specific immunotherapy treatments. The attempt to promoting the immune response to the vaccine intrapleurale Bacillus Calmette-Guérin (BCG), in fact, not mesothelioma and the treatment of patients who suffered this treatment had some side effects. Immunotherapy combination with interferon alpha has been able to reduce the tumor to 50% in some patients. The adverse effects of this treatment were minimal.
Heated intraopératoire intraperitoneal chemotherapy, a procedure developed by Paul Sugar Baker in Washington Cancer Institute is a breakthrough in the treatment of mesothelioma. It is in a position to remove a volume of the tumor through the direct administration of chemotherapy in the abdomen. In this treatment, high concentrations of certain drugs, which surfaces in abdomen and pelvis. The used fluid infusion for 60 to 120 minutes, then drained. When the drug is heated to 40 to 48 degrees Celsius, it increases the spread of drugs in the tissues. The heater for the malignant cells.
New approaches such as gene therapy are currently in clinical trials. Age, health problems, or the condition of advanced disease can lead to aggressive treatment. In such cases, palliative medicine, which treats the symptoms, it is ideal.